These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 26401940)

  • 1. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care?
    Teipel SJ; Keller F; Thyrian JR; Strohmaier U; Altiner A; Hoffmann W; Kilimann I
    J Alzheimers Dis; 2017; 55(4):1379-1394. PubMed ID: 27834778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data.
    Dyrba M; Barkhof F; Fellgiebel A; Filippi M; Hausner L; Hauenstein K; Kirste T; Teipel SJ;
    J Neuroimaging; 2015; 25(5):738-47. PubMed ID: 25644739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model.
    Kerbler GM; Hamlin AS; Pannek K; Kurniawan ND; Keller MD; Rose SE; Coulson EJ
    Neuroimage; 2013 Feb; 66():133-41. PubMed ID: 23128077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.
    Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ
    J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel S; Grothe MJ;
    J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease.
    Fellgiebel A; Yakushev I
    J Alzheimers Dis; 2011; 26 Suppl 3():257-62. PubMed ID: 21971465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
    Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
    Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements.
    Clerx L; Visser PJ; Verhey F; Aalten P
    J Alzheimers Dis; 2012; 29(2):405-29. PubMed ID: 22330833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.